Evidence map›Paper›PMID 24992594›Full record

ArticleInternational journal of molecular sciences2014

Effects of silica and titanium oxide particles on a human neural stem cell line: morphology, mitochondrial activity, and gene expression of differentiation markers.

Kouki Fujioka, Sanshiro Hanada, Yuriko Inoue, Keisuke Sato, Kenji Hirakuri, Kouichi Shiraishi, Fumihide Kanaya, Keiichi Ikeda, Ritsuko Usui, Kenji Yamamoto and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 31 citations in OpenAlex.

  1. Stem Cell Interventions in the Treatment of Alzheimer's Disease.Current stem cell research & therapy · 2025
    Review
  2. Article
  3. Review
  4. Stem cell therapy for Alzheimer's disease.World journal of stem cells · 2020
    Review
  5. Review
  6. New treatment modalities in Alzheimer's disease.World journal of clinical cases · 2019
    Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Kouki FujiokaDivision of Molecular Cell Biology, Core Research Facilities for Basic Science, The Jikei University School of Medicine, Tokyo 105-8461, Japan. kfujioka@jikei.ac.jp.
Sanshiro HanadaResearch Institute, National Center for Global Health and Medicine, Tokyo 162-8655, Japan. hanada@ri.ncgm.go.jp.
Yuriko InoueDepartment of Anatomy, Toho University, Tokyo 143-8540, Japan. yuriko.inoue@med.toho-u.ac.jp.
Keisuke SatoDepartment of Electrical and Electronic Engineering, Tokyo Denki University, Tokyo 120-8551,Japan. satok@mail.dendai.ac.jp.
Kenji HirakuriDepartment of Electrical and Electronic Engineering, Tokyo Denki University, Tokyo 120-8551,Japan. hirakuri@mail.dendai.ac.jp.
Kouichi ShiraishiMedical Engineering Laboratory, Research Center for Medical Science,The Jikei University School of Medicine, Tokyo 105-8461, Japan. kshiraishi@jikei.ac.jp.
Fumihide KanayaResearch Institute, National Center for Global Health and Medicine, Tokyo 162-8655, Japan. fkanaya@acc.ncgm.go.jp.
Keiichi IkedaDivision of Molecular Cell Biology, Core Research Facilities for Basic Science, The Jikei University School of Medicine, Tokyo 105-8461, Japan. ikedak@jikei.ac.jp.
Ritsuko UsuiDivision of Molecular Cell Biology, Core Research Facilities for Basic Science, The Jikei University School of Medicine, Tokyo 105-8461, Japan. ree-chicochamaro@jikei.ac.jp.
Kenji YamamotoResearch Institute, National Center for Global Health and Medicine, Tokyo 162-8655, Japan. ykenji@hosp.ncgm.go.jp.
Seung U KimMedical Research Institute, Chung-Ang University College of Medicine, Seoul 440-746, Korea. sukim@mail.ubc.ca.
Yoshinobu ManomeDivision of Molecular Cell Biology, Core Research Facilities for Basic Science, The Jikei University School of Medicine, Tokyo 105-8461, Japan. manome@jikei.ac.jp.
Jikei University School of Medicine · JPNational Center for Global Health and Medicine · JPTokyo Denki University · JPToho University · JPUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several in vivo studies suggest that nanoparticles (smaller than 100 nm) have the ability to reach the brain tissue. Moreover, some nanoparticles can penetrate into the brains of murine fetuses through the placenta by intravenous administration to pregnant mice. However, it is not clear whether the penetrated nanoparticles affect neurogenesis or brain function. To evaluate its effects on neural stem cells, we assayed a human neural stem cell (hNSCs) line exposed in vitro to three types of silica particles (30 nm, 70 nm, and <44 µm) and two types of titanium oxide particles (80 nm and < 44 µm). Our results show that hNSCs aggregated and exhibited abnormal morphology when exposed to the particles at concentrations = 0.1 mg/mL for 7 days. Moreover, all the particles affected the gene expression of Nestin (stem cell marker) and neurofilament heavy polypeptide (NF-H, neuron marker) at 0.1 mg/mL. In contrast, only 30-nm silica particles at 1.0 mg/mL significantly reduced mitochondrial activity. Notably, 30-nm silica particles exhibited acute membrane permeability at concentrations =62.5 µg/mL in 24 h. Although these concentrations are higher than the expected concentrations of nanoparticles in the brain from in vivo experiments in a short period, these thresholds may indicate the potential toxicity of accumulated particles for long-term usage or continuous exposure.

Indexed as

NanoparticlesCell LineHumansMitochondriaNestinNeural Stem CellsNeurofilament ProteinsSilicon DioxideTitaniumNestinneurofilament protein HNeurofilament ProteinsSilicon DioxideTitaniumtitanium dioxide

Identifiers

PMID24992594
PMCPMC4139811
OpenAlexW1964738319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.